Washington Trust’s Merck MRK Stock Holding History

Washington Trust’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.14M	Buy	34,430 +5,429	+19%	+$627K	0.14%	102
2025 Q4	$3.05M	Sell	29,001 -876	-3%	-$82.2K	0.1%	114
2025 Q3	$2.51M	Buy	29,877 +517	+2%	+$42.6K	0.08%	120
2025 Q2	$2.32M	Buy	29,360 +630	+2%	+$50.1K	0.08%	119
2025 Q1	$2.58M	Sell	28,730 -2,690	-9%	-$251K	0.1%	118
2024 Q4	$3.13M	Buy	31,420 +311	+1%	+$32.1K	0.11%	108
2024 Q3	$3.53M	Sell	31,109 -1,980	-6%	-$235K	0.12%	106
2024 Q2	$4.1M	Sell	33,089 -1,514	-4%	-$195K	0.15%	105
2024 Q1	$4.57M	Buy	34,603 +108	+0.3%	+$13.3K	0.17%	105
2023 Q4	$3.76M	Sell	34,495 -810	-2%	-$84.1K	0.15%	106
2023 Q3	$3.63M	Sell	35,305 -249	-0.7%	-$26.8K	0.16%	102
2023 Q2	$4.1M	Sell	35,554 -681	-2%	-$77.3K	0.17%	98
2023 Q1	$3.86M	Buy	36,235 +892	+3%	+$96.3K	0.17%	101
2022 Q4	$3.92M	Sell	35,343 -585	-2%	-$59.8K	0.18%	102
2022 Q3	$3.1M	Buy	35,928 +717	+2%	+$64K	0.16%	103
2022 Q2	$3.21M	Buy	35,211 +1,188	+3%	+$105K	0.15%	103
2022 Q1	$2.79M	Buy	34,023 +576	+2%	+$45.4K	0.11%	109
2021 Q4	$2.56M	Sell	33,447 -9,878	-23%	-$787K	0.1%	110
2021 Q3	$3.25M	Sell	43,325 -822	-2%	-$62.5K	0.09%	136
2021 Q2	$3.43M	Sell	44,147 -3,016	-6%	-$224K	0.1%	136
2021 Q1	$3.47M	Sell	47,163 -206	-0.4%	-$15.2K	0.11%	133
2020 Q4	$3.7M	Buy	47,369 +431	+0.9%	+$33K	0.12%	130
2020 Q3	$3.71M	Sell	46,938 -1,474	-3%	-$115K	0.14%	125
2020 Q2	$3.53M	Sell	48,412 -26,086	-35%	-$1.96M	0.15%	121
2020 Q1	$5.47M	Buy	74,498 +2,411	+3%	+$189K	0.26%	102
2019 Q4	$6.26M	Buy	72,087 +6,595	+10%	+$542K	0.25%	104
2019 Q3	$5.42M	Sell	65,492 -332	-0.5%	-$26.6K	0.29%	90
2019 Q2	$5.27M	Sell	65,824 -185	-0.3%	-$14.2K	0.29%	89
2019 Q1	$4.92M	Sell	66,009 -7,007	-10%	-$524K	0.28%	91
2018 Q4	$5.32M	Sell	73,016 -6,147	-8%	-$434K	0.34%	83
2018 Q3	$5.36M	Sell	79,163 -347	-0.4%	-$22.1K	0.29%	91
2018 Q2	$4.61M	Buy	79,510 +30,772	+63%	+$1.74M	0.25%	94
2018 Q1	$2.53M	Sell	48,738 -338	-0.7%	-$18.3K	0.15%	100
2017 Q4	$2.63M	Buy	49,076 +448	+0.9%	+$24.8K	0.15%	102
2017 Q3	$2.97M	Buy	48,628 +1,835	+4%	+$111K	0.18%	100
2017 Q2	$2.86M	Buy	46,793 +1,283	+3%	+$78.1K	0.17%	101
2017 Q1	$2.76M	Sell	45,510 -572	-1%	-$34.7K	0.17%	97
2016 Q4	$2.59M	Buy	46,082 +251	+0.5%	+$14.7K	0.17%	97
2016 Q3	$2.73M	Sell	45,831 -9,195	-17%	-$538K	0.18%	96
2016 Q2	$3.02M	Sell	55,026 -5,381	-9%	-$286K	0.2%	96
2016 Q1	$3.05M	Sell	60,407 -1,793	-3%	-$87.8K	0.2%	97
2015 Q4	$3.13M	Sell	62,200 -8,332	-12%	-$420K	0.21%	96
2015 Q3	$3.33M	Buy	70,532 +1,219	+2%	+$64.8K	0.24%	97
2015 Q2	$3.77M	Sell	69,313 -878	-1%	-$49.2K	0.25%	96
2015 Q1	$3.85M	Buy	70,191 +669	+1%	+$37.9K	0.26%	93
2014 Q4	$3.77M	Buy	69,522 +4,085	+6%	+$228K	0.26%	96
2014 Q3	$3.7M	Sell	65,437 -471	-0.7%	-$26.4K	0.27%	93
2014 Q2	$3.64M	Sell	65,908 -326	-0.5%	-$17.8K	0.27%	90
2014 Q1	$3.59M	Sell	66,234 -483	-0.7%	-$25K	0.27%	89
2013 Q4	$3.19M	Buy	66,717 +816	+1%	+$37.3K	0.24%	87
2013 Q3	$2.99M	Sell	65,901 -665	-1%	-$30.4K	0.24%	90
2013 Q2	$2.95M	Buy	+66,566	New	+$2.97M	0.25%	91

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Washington Trust's MRK Position: Q1 2026 in Review

Washington Trust increased its Merck (MRK) stake by 19% in Q1 2026, buying an estimated $627K and bringing the position to 34,430 shares worth $4.14M. The position accounts for 0.14% of the portfolio, ranked #102.

Washington Trust first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.26M in Q4 2019. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Washington Trust held 34,430 shares of Merck worth $4.14M as of Q1 2026.
Washington Trust bought 5,429 Merck shares in Q1 2026, an estimated $627K.
Merck made up 0.14% of Washington Trust's portfolio in Q1 2026, its #102 holding.
Washington Trust first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Washington Trust's Merck position peaked at $6.26M in Q4 2019.
3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Washington Trust's 13F filing for Q1 2026, filed 6 Apr 2026.